Drug-resistant TB: Rollout of shorter regimen hits a snag in South Africa

The much-anticipated rollout of the shorter regimen to treat drug-resistant tuberculosis (TB) has failed to make inroads leaving patients stranded across the country. Having started in March last year, only about 70 patients have received treatment – which is only being administered in four provinces. The new oral regimen can treat drug-resistant TB within a period of six months, instead of the usual 18 months. Read Here.
29 views0 comments

Recent Posts

See All

Mycobacterium tuberculosis (Mtb) has an unexpected vulnerability that future drugs may be able to exploit, according to a study from researchers at Weill Cornell Medicine. Read Here.